Latest News- Cell Therapy Market: Autologous is expected to lead the Type segment during 2025-2029

The Cell Therapy Market is being driven by Limitations in traditional organ transplantations fueling demand for cell therapies

The Cell Therapy Market is expected to grow at a CAGR of 21.7% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 15253 million. In the dynamic and innovative biotechnology sector, numerous small and large companies are spearheading research and development in cell therapy, focusing on various cell types such as progenitor cells, adult and embryonic stem cells, and induced pluripotent stem cells (iPS cells). These advanced cell types have demonstrated significant efficacy in addressing chronic conditions, including heart failure, cancer, and diabetes. While a considerable number of cell therapy products are commercially available for wound and dermal grafts, the market for cancer treatments remains limited. The geographical hotspots for cell-based immunotherapy clinical trials are primarily in the United States and European countries. With the expanding scope of cell therapy applications, approximately 300 companies and institutions are actively engaged in over 1,900 clinical trials worldwide. 

Get more information on Cell Therapy Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Type
  • Autologous
  • Allogenic
• Application
  • Malignancies
  • Musculoskeletal
  • Cardiovascular
  • Others
• End-user
  • Biopharmaceutical companies
  • CMOs
  • CROs
  • Academic and research institutes
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia
    • China
    • Japan
    • South Korea
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Limitations in traditional organ transplantations fueling demand for cell therapies
• Increasing funding in cell-based research
• Proven effectiveness of CAR T-cell therapy

However, the market also witnesses some limitations, which are as follows:

• High cost and failure rate in clinical trials
• Strict regulatory approval for product launch of cell therapy products
• Ethical concerns related to stem cell research

Benefits of Buying Global Cell Therapy Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Cell Therapy Market Research Report

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Cell Therapy Market encompasses advancements in cell manufacturing, including characterization and assessment of immunogenicity. Preclinical development involves in vivo imaging, disease modeling, and biomarker discovery. Tumor microenvironment research incorporates drug combination strategies, oncolytic viruses, and viral transduction. Targeted therapies utilize stem cell niche understanding, cell fate determination, and homing mechanisms. Cell tracking technology, microfluidic devices, and 3D cell culture are essential for high-throughput screening. Disease-specific cell types, antibody engineering, and receptor engineering are also significant areas of focus. (51 words)

Market Research Overview

The autologous and allogeneic cell therapy segments are key areas of focus within the burgeoning cell therapy market, encompassing companies and research organizations engaged in the development and manufacturing of treatments utilizing mesenchymal stem cells and hematopoietic stem cells. According to Technavio, the global pharmaceuticals market, inclusive of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services, is poised for significant expansion. Factors driving this growth include the increasing aging population, with Europe and North America projected to have over 25% of their populations exceeding 60 years by 2030 and 2050, respectively. This demographic shift will fuel demand for advanced medical solutions, including cell therapies, to address age-related health concerns.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/